
Preparing for the Next Bear? Let’s Build a Portfolio That Doesn’t Just Hibernate
So... are we just going to pretend we don’t see that big fuzzy bear looming in the distance? 🐻
It’s wearing a tie, licking its chops, and holding a sign that says “Shiller PE: 38.37.” 🐻📉🧠
Let’s recap:
The market is expensive. The Current Shiller PE Ratio for the S&P 500 (known as the Cyclically Adjusted PE Ratio), which is based on average inflation-adjusted earnings from the previous 10 years, is a daring 38.37.
📊 Metric | Value |
---|---|
Mean PE | 17.26 |
Median PE | 16.05 |
Current | 38.37 |
Max (1999) | 44.19 |
Min (1920) | 4.78 |
So yeah, it’s expensive. Maybe not dot-com bubble yet, but the room’s getting warm and someone’s playing techno.
🧭 So what now? Prepare the portfolio. Don’t panic. Diversify like a ninja.
We’re not trying to beat the bear in arm wrestling. We’re just trying to outsmart it. Here are 5 areas I’m eyeing — and why:
🥇 1. Gold & Gold Miners: Dig In
Gold’s been shiny since ancient times — but now it’s practical too.
Barrick Mining (B) has a P/E of 16.31 and forward P/E of 12.18.
Paulson owns 23% of Perpetua Resources (PPTA). That’s not lunch money.
👉 Want the full picture? Dive into Barrick Mining ($B)'s financials here.
💰 2. Classic Value Stocks: Some Deals, Hold the Drama
PepsiCo (PEP)? Still refreshing.
American Tower (AMT)? High places.
UnitedHealth (UNH)? After the fall, maybe it’s time to heal.
And Elevance Health (ELV)? The CEO bought in. That’s some healthy conviction.
💡💡💡 Curious about those deep oil exploration plays?
Check our takes on UnitedHealth Group or even Oscar Health.
🧪 3. Biotech, Pharma & The Underdog Gene Whisperers
Pfizer (PFE) = battered but not broken.
Moderna’s CEO bought shares not too long ago.
Biotech ETF XBI trades ~50% below ATH and has 0 analyst sell ratings — like, none.
Also: Crispr Therapeutics (CRSP). That’s science fiction turning science fact.
🌐 4. International Plays: Diversify or Die Trying
Alibaba? Louis Vuitton? You’re telling me these are riskier than paying 38x earnings for U.S. megacaps?
I’ll take my chances with the baguette and the dragon, thank you.
💀 5. Companies Already in a Bear Market (and Maybe Clawing Back)
PayPal (PYPL): Not the belle of the payments ball anymore.
Estee Lauder (EL): Got roughed up at the glam table.
But come on — how much lower can they go?
🎯 Final Thought: Don’t try to be a hero. Just don’t be the last one holding overpriced tech when the bear shows up with a salad fork.
I’m prepping this “Down But Not Doomed” portfolio. It won’t make me rich in a crash — but it might make me less poor. 😅
Got other ideas? Hit me up. I’m not married to PayPal.
⚠️ Disclaimer:
This isn’t investment advice. It’s just a second opinion — and yes, we’re billing your sense of humor. 🎪💸
Invest at your own risk, always DYOR, and don’t invest what you can’t afford to lose.
🧭 Want More Like This?
- 🕵️ Insider Purchases Center
- 📣 Follow the Pundits Hub
- 📈 Young Guns & Turnaround Stocks — Track More Growth (and Growing-Pain) Plays
- 😆 Stock Market Humor & Serious-ish Plays
- 🌍 See the world differently and check out more international market picks and fun takes. Explore International Investment Opportunities and value plays 💸 Cheap Stocks with (Maybe) Big Upside
- 🧟 Corporate Resurrection Series — Our special series on companies rising from the financial grave. 🎯 The “Turnaround or Toast” Series (If it still exists. We’re not sure. Ask the intern.)
- 📈 Biotech Bets & Innovation Radar (Problem is we can't detect the Radar)
😂 Laugh, Learn, Invest: funanc1al.com | Funanc1al: Where Even Finance Meets Funny
Other articles:
Quick links
Search
Privacy Policy
Refund Policy
Shipping Policy
Terms of Service
Contact us
About us
FUNanc!al distills the fun in finance and the finance in fun, makes news personal, and helps all reach happiness.
Got a thought? A tip? A tale? We’re all ears — drop it below.: